Back to Aberdeen Group plc Aberdeen Group plc

AMLXAMLX
Showing 6 of 9 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in AMYLYX PHARMACEUTICALS INC

Aberdeen Group plc holds 737,670 shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $13.2M as of 2026-Q2. This is a new position. AMLX represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$13.2M

Current Shares

737,670

Total Value Change

+$6.9M

Total Shares Change

-1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
737,670
-
$13.2M0.0%$17.96
39
2025-Q3
Exited
0
-100.0%
$00.0%$14.90
0
2025-Q2
Decreased
738,657
-69.6%
$4.7M0.0%$6.33
0
2025-Q1
Increased
2.4M
+41.1%
$8.6M0.0%$3.66
37
2024-Q4
Decreased
1.7M
-12.7%
$6.5M0.0%$3.84
0
2024-Q3
Increased
2M
+1567.9%
$6.4M0.0%$3.08
44

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used